| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6168807 | Urology | 2010 | 5 Pages |
Abstract
Our study represents the largest and the only population-based analysis of cancer control efficacy of NSS vs RN in T1bN0M0 RCC. It indicates that NSS does provide equivalent cancer control relative to RN. In consequence, based on cancer control equivalence, NSS should be given equal consideration to RN in patients with T1bN0M0 lesions.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Maxime Crépel, Claudio Jeldres, Paul Perrotte, Umberto Capitanio, Hendrik Isbarn, Shahrokh F. Shariat, Daniel Liberman, Maxine Sun, Giovanni Lughezzani, Philippe Arjane, Hugues Widmer, Markus Graefen, Francesco Montorsi, Jean-Jacques Patard,